Package 68001-642-41

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 68001-642-41
Digits Only 6800164241
Product NDC 68001-642
Product ID 68001-642_3ff1337b-204f-2c46-e063-6394a90a4ebe
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (68001-642-41) / 10 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-05-01
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Decitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3ff1337b-204f-2c46-e063-6394a90a4ebe", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0368001642415"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["de303068-589e-4e0a-90ed-e60b2c1a2b56"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-642-41)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-642-41", "marketing_start_date": "20250501"}], "brand_name": "Decitabine", "product_id": "68001-642_3ff1337b-204f-2c46-e063-6394a90a4ebe", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-642", "generic_name": "Decitabine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/10mL"}], "application_number": "ANDA215355", "marketing_category": "ANDA", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}